Evidence map›Paper›PMID 24318886›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2014

Design and analysis of hammerhead ribozyme activity against an artificial gene target.

James R Carter, Pruksa Nawtaisong, Velmurugan Balaraman, Malcolm J Fraser

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James R CarterDepartment of Biology, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Pruksa Nawtaisong
Velmurugan Balaraman
Malcolm J Fraser
University of Notre Dame · US

Funding

Developing Anti-viral Ribozymes to Suppress Arboviruses in Transgenic MosquitoesR01AI097554 · NIAID · UNIVERSITY OF NOTRE DAME · PI FRASER, MALCOLM J. · 2012 to 2016
$2.8M
NIAID NIH HHS AI097554NIAID NIH HHS R01 AI097554
6 · The paper itself

Abstract

In vitro cleavage assays are routinely conducted to properly assess the catalytic activity of hammerhead ribozymes (HHR) against target RNA molecules like dengue virus RNA. These experiments are performed for initial assessment of HHR catalysis in a cell-free system and have been simplified by the substitution of agarose gel electrophoresis for SDS-PAGE. Substituting mobility assays enables the analysis of ribozymes in a more rapid fashion without radioisotopes. Here we describe the in vitro transcription of an HHR and corresponding target from T7-promoted plasmids into RNA molecules leading to the analysis of HHR activity against the RNA target by in vitro cleavage assays.

Indexed as

CatalysisDengue VirusElectrophoresis, Agar GelHumansKineticsMolecular BiologyRNA, CatalyticRNA, Viralhammerhead ribozymeRNA, CatalyticRNA, Viral

Identifiers

PMID24318886
PMCPMC4219533
OpenAlexW1724453951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.